FAPI-PET for Tumor Detection

Recruiting now

Conditions studied: Malignant Neoplasm

In brief

This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.

Key facts

Study ID

NCT04571086

Run by

University Hospital, Essen

People needed

500

Starts

2020-04-30

Expected to finish

2027-04-30

Last updated by the study team

2023-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy
• Age ≥ 18 years.

You may not qualify if…

• Patient cannot give consent for the study
• Patient can not lie flat or tolerate FAPI PET imaging
• Unwillingness or inability to comply with study and follow-up procedures
• Condition of patient which is critical to participate in this study in the discretion of the investigators
• Pregnant, lactating, or breast feeding women.

Where it is running

• Department of Nuclear medicine, University hospital Essen — Essen, North Rhine-Westphalia, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.